UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934


         Date of Report (Date of earliest event reported) April 2, 2006

                             OrganiTECH U.S.A. INC.
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

         Delaware                  000-22151                    93-0969365
- --------------------------------------------------------------------------------
(State or other jurisdiction      (Commission                  (IRS Employer
      of incorporation)           File Number)               Identification No.)


Yoqneam Industrial Area, P.O. Box 700, Yoqneam 20692, Israel
- --------------------------------------------------------------------------------
         (Address of principal executive offices)                     (Zip Code)


       Registrant's telephone number, including area code 972-4-959-0515

- --------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[_]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[_]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

[_]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[_]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))

- --------------------------------------------------------------------------------

ITEM 8.01 OTHER EVENTS


ORGANITECH REPORTS THE RESIGNATION OF ONE OF ITS DIRECTORS

Dr. Mark Friedman who served as OrganiTECH's Director since 2003 announced his
resignation from OrganiTECH's Board of Directors effectively from March 27,
2006.




                                    SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.



                                                         OrganiTECH U.S.A., INC.
                                                         (Registrant)
Date   April 2, 2006

                                                         By :/s/ Yaron Shalem
                                                         --------------------
                                                         (Signature)
                                                         Yaron Shalem
                                                         Chief Financial Officer